Letrozole and Adjuvant Therapy for PCOS-Induced Ovulation

Completed Phase 3 NCT06405178

Study Description

A Study Evaluating the Effectiveness of Letrozole with Metformin, Dapagliflozin, or a Combination in Inducing Ovulation in Women with Polycystic Ovarian Syndrome (PCOS)

Study Details

Registry ID:
NCT06405178
Conditions:
Polycystic Ovary
Phase:
Phase 3
Target Enrollment:
200 participants
Start Date:
Age Range:
20–40 years
Gender:
Female
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →